alexa Yibing Qyang | Yale Cardiovascular Research Institute
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Yibing Qyang

Yibing Qyang Yibing Qyang
Principal Investigator
Yale Cardiovascular Research Institute
USA
Biography

Yibing Qyang obtained his B.S. degree from the Department of Biochemistry, Nanjing University, China. He subsequently pursued graduate studies at the Institute of Microbiology, Chinese Academy of Sciences. Then, he joined the Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center. After receiving his M.S. degree from Dr. Michele Sawadogo’s laboratory, and Ph.D. degree from Dr. Stevan Marcus’, he spent the next year conducting postdoctoral research at Baylor College of Medicine, where he studied myeloproliferative diseases with a mouse model of Presenilin deficiency. He next joined Dr. Kenneth R. Chien's laboratory at the University of California, San Diego and Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School and Harvard Stem Cell Institute. He has been studying the renewal and differentiation of cardiovascular progenitor cells, marked by Isl1, a LIM-Homeodomain transcription factor. In October, 2008, Yibing Qyang became a principal investigator at Yale Cardiovascular Research Institute and Section of Cardiology, Dept. of Internal Medicine, and Yale Stem Cell Center. Since 2010, he has become the Director of Yale Stem Cell Research Forum.

Research Interest

renewal and differentiation of cardiovascular progenitor cells, marked by Isl1, a LIM-Homeodomain transcription factor.

Publications

Application of iPS Cell Technology for Cardiac Disease Modeling and Repair

Amogh Sivarapatna, Oscar Bartulos, Carol Y. Suh and Yibing Qyang

Editorial: J Clinic Experiment Cardiol 2012

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords